Announcements Trials
Browse Landscape

Status

Active not recruiting 4Recruiting 3Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 63Cisplatin 41Pemetrexed 39Drug Therapy 37anlotinib 23osimertinib 22Etoposide 19tislelizumab 18Paclitaxel 18Radiotherapy 17Surgical Procedures, Operative 16pembrolizumab 15toripalimab 14130-nm albumin-bound paclitaxel 14aflutinib 13Docetaxel 13Bevacizumab 12sintilimab 10Specimen Handling 10Magnetic Resonance Spectroscopy 10durvalumab 9Injections 9cemiplimab 8Radiosurgery 8Platinum 8PM 01183 8Immunotherapy 8atezolizumab 7Platinum Compounds 7Blood Specimen Collection 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × entrectinib × Thoracic × Clear all
NCT06694129 2024-11-19

Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

National Cancer Center, China

Not yet recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡